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Abstract. The burden of kidney failure remains largely underreported in East Africa. 
Health systems face numerous challenges including a lack of kidney registries, shortages 
of trained skilled healthcare workers, a lack of diagnostic support, a lack of equipment, and 
underdeveloped policies to govern the provision of treatment for kidney failure. Kidney 
transplantation, an effective treatment option against kidney failure, is underused 
primarily because of its cost and the lack of laws governing it. In this paper, the author 
discusses the salient issues affecting kidney donation and transplantation in East Africa. 
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1. Introduction  
cross the globe, End-Stage Renal Disease (ESRD), kidney failure1, a 
non communicable disease, silently devastates numerous lives. 
Kidney failure has had a great impact on global morbidity (being 
diseased) and mortality (being susceptible to death)because it increases risks 
associated with other major killers: heart diseases, high blood sugar 
(diabetes), high blood pressure (hypertension), infection with Human 
Immunodeficiency Virus (HIV), tuberculosis, and malaria. Kidney failure, 
commonly described as persistent kidney damage accompanied by a 
glomerular filtration rate (GFR) of less than 15mL/min/1.73m2 (compared to 
a normal range of 90-120mL/min/1.73m2) and the presence of proteins in 
urine, is estimated to have caused 1.2 million deaths globally in 2015. Kidney 
failure can coexist with progressive chronic nerve damage in patients. It is 
associated with the inability to excrete waste, control serum minerals 
(electrolytes), handle daily dietary and metabolic acid load, and maintain 
fluid balance. It subsequently results in inadequate production of hormones 
by the kidneys,2 deranged calcium and phosphorus metabolism, high blood 
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1 Kidney failure in this article is used to mean End-Stage Renal Disease (ESRD). 
2 Hormones: erythropoietin secreted by kidneys increases the rate of production of red blood 
cells in response to falling levels of oxygen; calcitriol (the active form of vitamin D) increases 
calcium levels in body in skeletal and tissues diseases; and renin raises blood pressure.  
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pressure, and accelerated progression of heart diseases, cancers, diabetes 
and neurological disorders.3 
Due to scanty epidemiological information, poor accessibility of 
laboratory and other diagnostic services, and the widespread lack of 
awareness, kidney failure remains a “silent killer,” especially in low-income 
countries where many sufferers may not receive a diagnosis. And yet, 
medical technology has provided an efficacious intervention: kidney 
transplantation. Kidney donation and transplantation, a form of renal 
replacement therapy (RRT), is the most valued treatment for patients with 
kidney failure today. The prevalence of kidney failure is such that almost 
every country in the world faces the daunting task in supplying an adequate 
number of kidneys for transplantation (Randolph, David & Rigmar, 2013).  
Successful kidney transplantation is common in developed countries, but 
rare or nonexistent in many low-income countries, including Uganda, where 
I live. The procedure poses severe challenges. Registries for would-be 
recipients and donors are non-existent. Many people have poor health habits 
and lack money or proximity to gain access to healthcare. Also, most 
sufferers from kidney disease show no symptoms at first. If kidney disease 
is detected, it is often in the few advanced health facilities available, and at 
the late stages of the disease. The true extent of kidney failure is actually 
unknown in most East African countries—a gap that must be filled. 
Babau et al.(2015), in a study at a national referral hospital in Uganda, 
indicated that up to 51% of 111 patients attending the outpatient nephrology 
department had kidney failure. Unfortunately, no nation-wide data are 
available to confirm or dispute this one-site statistic.  
It is estimated that about 2.62 million people received dialysis in 2010 
globally and the need is projected to double by 2030. In 2017, age-
standardized incidence of kidney failure treated with dialysis increased by 
43.1%, while incidence treated with transplantation increased by 34.4% 
(Cockwell & Fisher 2020).4Analyses indicate that the total cost of treatment 
of milder chronic kidney disease (CKD) is much higher than the total cost of 
treating kidney failure by kidney replacement therapy (Randolph, David & 
Rigmar, 2013). This economic burden will be discussed later in this paper. 
 
2. Brief medical background for those unfamiliar with 
kidney disease and transplantation 
Before the firsts uccessful kidney transplantation was performed, the 
choice for patients with kidney failure was either kidney dialysis or death. 
In 1954, Dr. Joseph Murray and his team performed the first successful 
kidney transplant, using identical twins (Anthony, 2012).  
 
3 The following references are pertinent to the discussion in this paragraph: Murry et al. 2015; 
Jiro & Yuji 2017; Seyid, Fetimah, Shokouh & Seyid, 2015; Leticia & Charlotte 2012; Jack, 
Corine & David 2020; Jinsoo, et al. 2018; Rashad, 2020; Geraldo, et al. 2017; Eriksen & 
Ingebresten, 2006; Elisabetta & Giorgina 2019; Oncohema Key, [Retrieved from]. 
4  The 95% confidence intervals of these two figures are 40.5%-45.8% and 29.7%-38.9%, 
respectively. 
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Gradually, the transplantation procedure was established worldwide. 
The transplantation procedure still remained unsuccessful when an identical 
twin was not available, because of negative immunological reactions. 
Cyclosporine, a “wonder drug” discovered in the 1970s, suppressed adverse 
immunological reactions in patients and increased survival rates in 
transplant patients significantly. Kidney transplants subsequently became a 
much valued treatment for patients with kidney failure. In addition to 
increasing transplants between living related individuals, cyclosporine 
made transplantation between living unrelated individuals a medically 
successful procedure. Success increased the demand for transplantation, but 
the shortage of organs has emerged as a major hindrance in reaping all the 
benefits of these advances (Thomas, 2011; Anthony, 2012; Barker & 
Markmann, 2013). 
 
3. Risk factors for kidney failure 
Risk factors for kidney disease include diarrheal diseases, HIV infection, 
low birth weight, pre-term birth, and malaria. These are leading causes of 
disability and cover lifestyle, infection, and environmental etiologies. 
Identifying risk factors early and taking steps to counteract them can help 
prevent acute kidney injury (AKI) and chronic kidney disease. Early 
diagnosis can help slow the deterioration of kidney function and therefore, 
avert chronic kidney disease by inexpensive interventions (Neema et al. 2019; 
Murray et al. 2015).  
Poverty. Poverty compounds the problems of kidney disease. Poverty-
related kidney disease is associated with infections, low education, poor 
maternal health, inadequate access to healthcare, and strenuous or 
hazardous work, among other factors (Norton et al., 2016). Poverty is also 
associated with a lack of social protection, transportation, and 
unemployment, as well as poor housing. Lack of transportation alone can 
impede access to healthcare even in situations where treatment costs are not 
a major barrier. In most cases, the treatment costs are directly covered by the 
patients and it is an up-hill task to obtain out-of-pocket fees to cover dialysis 
and simultaneously pay for the monthly supply of medications required in 
kidney failure management, transplantation costs, and post-transplantation 
medications. Reducing the financial hardships faced by patients suffering 
from kidney failure in Uganda is paramount, and financial support is equally 
needed for patients preparing for transplants and those in post 
transplantation life. As a later section will discuss, Kenya and Tanzania have 
each instituted a National Health Insurance Fund (NHIF) that covers part of 
the cost for kidney transplants.  
Diet. Healthy pre- and post-transplantation life requires that patients 
follow recommended diets. Some East Africans are malnourished, 
predisposing them to diarrhea, pneumonia, and other infections that are 
important risks for kidney disease. In adolescents, undernutrition results in 
underweight mothers, low-birth weight offspring, preterm births, pre-
eclamptic pregnancies, gestational diabetes, and maternal obesity, all of 
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which increase the lifetime risk of chronic kidney disease in mothers and 
children (Freudenberg, 2016). 
Adequate nutrition is key in reducing chronic kidney disease, yet 
communities with low incomes at times have limited access to healthy foods. 
Community-based strategies, which include public sensitization and 
education about healthy food choices, fat reduction, salt reduction, 
legislation (taxes on high-sugar foods and soft drinks), and regulations on 
the provision of public meals (say, in parties, schools, and funerals, among 
other places) can help improve kidney health and are a much-needed 
intervention to save lives. 
Sex. Women with chronic kidney disease in East Africa face greater 
challenges than men do. Their involvement in childcare, housework, small-
scale agriculture, and low-income manual work explains why fewer women 
than men receive treatment for kidney disease when compared with men. 
Societal gender-based issues such as child marriage, poor access to family 
planning, and beliefs that women may not perform marital duties after 
transplantation are all factors for the shortage of organs for transplantation 
(Cobo et al., 2016). Advocacy for equity aimed at betterment of women’s 
health can decrease the burden of kidney disease. 
Drinking water. Most of East Africa lacks access to safe drinking water. 
Hence, waterborne diseases that cause acute kidney injury and chronic 
kidney disease are far more common than in richer countries. Enteric 
waterborne diseases like diarrhea and non-enteric diseases caused by 
waterborne pathogens like schistosomiasis can cause kidney disease. Other 
water-related causes of kidney injury may include consumption of water 
contaminated with heavy metals, organic acids, or pesticides. Prolonged 
dehydration also contributes. 
Environmental change. Climate change, land degradation, deforestation, 
degradation of biodiversity, and loss of marine life also significantly increase 
risk of kidney disease. These same factors also increase the risk that kidney 
disease will progress to a chronic condition through increasing human 
contact with vector borne diseases such as malaria, try panasomiasis, 
schistosomiasis, yellow fever, dengue fever, and increasing food insecurity 
(Johnson et al. 2016; Vonesch et al. 2016). 
Influence of urbanization. There is limited information on the influence of 
urbanization in East Africa on kidney disease. However, changes in lifestyle, 
including a switch to high-calorie food, reduced physical activity, sodium-
rich foods, higher environmental pollution, poor sanitation, poor waste 
management, and limited infrastructure resources all increase risks for 
kidney disease. Urban planning to improve hygiene and sanitation, reduce 
population densities, and reduce transmission of pathogens should decrease 
incidence of acute kidney injury and chronic kidney disease (Giles-Corti et 
al., 2016). Other urban-related risk factors like road-traffic collisions causing 
kidney damage, natural disasters, and armed conflicts causing crush-injury-
induced acute kidney injury, rural-urban migration and immigration all 
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contribute to the burden of chronic kidney disease in East Africa (McPhee et 
al.2015; Sever et al. 2012). 
 
4. Problems with treatment of kidney disease in East 
Africa 
In East Africa, there are enormous challenges in managing end-stage 
kidney failure. They include late diagnosis, as the condition is confirmed 
after worsening of kidney function, poor personal behavioral factors like 
physical inactivity, high salt intake, and tobacco use, improper drug 
therapies, lack of counseling, diabetes, and high blood pressure. When 
kidneys fail, kidney replacement through transplantation is the only option 
that allows patients to live normal lives. However, there is a great shortage 
of kidneys for transplantation due to the lack of legislation supported by the 
local community, lack of ethical and moral approval, scarcity of professional 
skill, lack of quality equipment, and institutions. Even where transplants 
occur, there are not enough kidneys for therapeutic purposes from deceased 
and uncompensated living donors to meet the supply. Consequently, 
thousands who cannot get transplants in time die. 
Such circumstances have led economists, doctors, medical diagnostic 
scientists and other concerned personnel to call for compensating living 
donors to meet the supply of kidneys and other organs needed for 
therapeutic purposes (Frank, Phillip & Glenn 2018; Phillip et al. 2018; Sally 
2016; Randolph, David & Rigmar 2013). However, laws established in Kenya 
and Tanzania stand in the way of doing so because they prohibit 
compensation. These laws are grounded in moral repugnance of paying 
organ donors and concerns that poor people will sell their organs for small 
sums inadequate to compensate them for the risks they are taking (Phillip et 
al. 2018). It is also worth mentioning that Uganda today has no laws to 
govern organs and kidney donation, transplantation, and compensation of 
donors. 
 
5. Nearly global shortage of kidneys for transplantation 
A kidney shortage exists nearly in all countries of the world because many 
potential free-will donors do not come forward. Costs associated with 
evaluation and donation, the risk of dying without life insurance, concerns 
about long-term healthcare without health insurance, lost wages while out 
of work for surgery and recovery, and the cost for travel to a transplant 
center for evaluation and surgery all hinder altruistic donation. 
Compensation would increase availability of kidneys for transplants. 
Transplantation remains the preferred therapy because the average total cost 
of kidney dialysis is considerably higher than estimates suggest would be 
the case if everybody who needed a transplant could obtain one. 
Transplantation also improves quality of life and health related outcomes 
compared to dialysis (Randolph, David & Rigmar, 2013). 
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In their paper on the global organ shortage, Randolph and his colleagues 
performed detailed analysis of literature on both organ shortage and 
potential solutions, and argue that compensating organ donors, both living 
and cadaveric, is by far the best way of increasing supply. Their evaluation 
is not restricted to compensation; they also look at changes in default donor 
rules (such as shifting to presumed consent), improved collection procedures 
(the Spanish model), organ chains and swaps, demand management, etc. 
They argue that even if compensation would add to the costs of a transplant, 
it is no objection because even a modest increase in the supply of kidneys 
would reduce the costs of dialysis by more than enough to compensate the 
kidney donor. Thus, net health care costs would decline, rather than increase, 
with compensation. 
There are some countries where some forms of compensation to donors 
are allowed. In these countries, compensation is not robust and direct, and 
although it seems to have increased the number of donors, shortages of 
organs remain. Some observers have argued for systems of regulated 
incentives to encourage kidney donation (Sally 2011, 2016). The major reason 
to consider incentives for living kidney donation is that transplant 
candidates are suffering and dying while waiting for transplants (Matas, 
2011). In addition, the longer the patient waits on dialysis, the worse the 
transplant results (David et al. 2018; Cosio, 1998). The other reason for 
considering incentives is that currently unregulated black markets exist 
globally. Only the wealthy receive kidneys in these markets, and there is 
little or no oversight for donor evaluation, no long-term donor follow-up, 
and no protection for the donor, or the recipient. In such black market 
arrangements, the donor at times does not even receive what was promised. 
Developing a regulated system of incentives may decrease the waiting list 
and eliminate these unregulated black markets (Schiano & Rhodes, 2010). 
Incentives could also be considered for donation by deceased persons, 
though it might be difficult to determine who would receive the incentives 
if family members disagree. In Uganda, for example, there is no clearly 
defined order for determining the next of kin. Different options for 
incentives could be provided. There could be a tax credit, college tuition, or 
a small direct payment with additional small amounts at each follow-up 
visit. These would minimize the risk of candidates donating for “quick cash” 
and help ensure long-term follow-up. Different incentives could appeal to 
different candidates and thus help increase availability of kidneys and save 
lives (Matas, 2011). 
 
6. Iran—the only exception 
There is one country where compensating kidney donors is legal: Iran, 
although it does not have kidney shortages. Iran began kidney transplants 
in 1967, but surgeries slowed down in the 1970s due to several factors. 
Through the 1980s, patients were allowed to travel abroad for transplants, 
but, because of high costs, an ever-increasing waiting list of patients, and 
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Iran’s eight-year war with Iraq, the country was forced to abandon the travel-
abroad program. In 1988, Iran created the program it has today (Mitra, 2012). 
In Iran, a person needing a kidney is referred to the Dialysis and 
Transplant Patients Association, which matches those needing a kidney with 
a potential healthy adult donor. The government pays for the surgeries, 
while the donor receives health coverage for at least a year and reduced rates 
on health insurance for subsequent years from government hospitals. Those 
who broker the connection receive no payment. They help negotiate the 
financial compensation the donor receives, usually an equivalent of $4,500, 
which is roughly 80% of GDP per person. They also help determine whether 
Iranian charities or wealthy individuals can cover the costs for those who 
cannot afford to pay for a kidney. Today, more than 1,480 people receive a 
kidney transplant from a living donor in Iran each year. Some 2,500 people 
undergo dialysis each year, but most do not seek transplants because they 
suffer other major health problems or are too old. 
Iran says its system safeguards against black-market organ sales by 
having non-profit groups handle all arrangements and hold money in 
custody until after the surgery. The government’s Health Department 
approves all surgeries, which must take place in licensed and monitored 
hospitals. Foreigners are largely banned from taking part, suppressing the 
possibility of medical tourism, though Iranians who are dual nationals can 
benefit from the program. This unique system has thus allowed those in need 
of a transplant to buy a kidney and has seen Iran’s waitlist for kidneys 
effectively drop to zero (Mitra, 2012; Samuel, 2018). 
East Africa has barriers to kidney donation that include lack of relevant 
policies and legislation, stringent cultural and religious taboos, supply 
shortages of essential medications, limited epidemiological data, lack of a 
relevant workforce capacity, lack of sufficient and standard infrastructure, 
poor research capacity in kidney failure, and low social economic status that 
cannot reliably sustain out-of-pocket payments needed for temporal 
management during dialysis and post-transplantation life. Despite these 
problems, a concerted effort by free-will advocacy groups, government 
leaders, researchers, educationists, politicians, and other well-wishers might 
help establish a kidney donation and transplantation system that alleviates 
the shortage of organs by ensuring that donors are compensated. 
 
7. Treatment of kidney disease in East Africa: dialysis 
Kenya and Tanzania have many kidney dialysis centres and transplant 
facilities; the exact number for Kenya is unknown. In Uganda, there are few 
renal dialysis centres. There are no data available to estimate the number of 
people on renal dialysis in Uganda or the cost- a gap that needs to be filled. 
Most dialysis centres are located with-in Kampala (the capital city) and some 
others are scattered in upcountry towns. The government of Uganda has 
instituted one dialysis centre at the national referral hospital. It has 25 
dialysis machines, which are too few to serve the whole population of 45 
million Ugandans. Some patients miss out on dialysis because they have to 
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buy the supplies for the dialysis machine and pay a service fee of about $20 
(60,000 Ugandan shillings) per session at the government-owned facility, 
which, for many Ugandans, is a substantial amount. Other renal dialysis 
centres are run under private-public collaborations or are fully private. 
Under private-public arrangements, a government-run regional referral 
hospital can house a renal dialysis centre, but the service is entirely private 
and has to be paid for directly by the patient. The cost of the service under 
this arrangement varies across facilities, but a typical amount is $100 (350,000 
shillings) per session, a very high amount for many Ugandans. It is worthy 
to note that this also comes with the need to pay for drugs, the dialysis 
circuit, and other accessory expenses like transportation of patient and 
caregivers, accommodation, and feeding. The total monthly bill for patients 
comes to over $2,500 (8.75 million shillings) per month, equivalent to 390% 
of GDP per person. About 85% of this amount goes to cover dialysis and 
drugs. Even for formally employed Ugandans, $2,500 amounts to14-16 
months earnings. For peasants, it is an even higher burden.  
 
 
Figure 1. A patient undergoing dialysis at a regional referral hospital in Uganda. 
According to the dialysis attendant, two more patients were expected to have dialysis on 
this day but were unable to make it because of costs. 
 
To illustrate the challenges dialysis patients face, Iinterviewed several. 
Rutahira Ram is a 21 year old man who was having his first dialysis session 
at Mbarara Regional Referral Hospital (MRRH) with hopes his kidneys can 
recover back to normal function. (To protect privacy, all names of patients 
and family members here and in later sections have been changed.) 
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“I have had to sell some of my goats and ask some family members for 
financial help in order to manage the dialysis sessions required this 
month and with the COVID-19 lockdown, transport from my village 
was so expensive… I can only hope that I recover so fast.” 
 
Rutahira Ram is a Bachelor of Laws student. He expressed discomfort 
with his unpredictable future because of the labour some and expensive yet 
compulsory dialysis he has to receive thrice every week, as he wonders 
whether he will be able to complete his academics.  
 
“I hope I could complete my bachelor’s. I only ask government to 
provide us more dialysis centres in our rural towns so that we do not 
have to cover long distances and lose a lot of time.”  
 
Kyobuzaire Evas is a student pursuing a Bachelor of Business 
Administration, a last-born child and a caregiver to her 55 year old mother, 
who has spent a year on renal dialysis services. She notes that renal dialysis 
expenses have had a great negative impact on their family as a whole.  
 
“The cost has been so heavy on us. We have had to sell off big parts of 
our family land, in order to care for our mother.” 
 
As a family, they have not tried to get a kidney donor because they think 
it is very expensive and know that a kidney transplant is not done in Uganda. 
She admits they are not so knowledgeable about kidney donation, 
compensation, and transplantation opportunities in Uganda, as they hail 
from one of the deep rural areas in Uganda.  
 
“Government of Uganda should step in to reduce the cost, equip 
hospitals with more dialysis equipment and create awareness in the 
population of existence of kidney failure. Many people are suffering 
and dying unknowingly, thinking they have been bewitched as they 
wonder why they seem not to pass out urine as usual. Many suffer a 
mild state of confusion which is why they call it witchcraft.” 
 
“We would as a family welcome a kidney donor and proceed to do a 
transplant but I request government to step in up and set standard 
requirements and guiding laws and put up a public fund to support poor 
kidney failure patients,” she asserts, with a frown on her face. 
 
8. Treatment of kidney disease in East Africa: 
transplantation 
Uganda currently refers all patients who require kidney transplants 
abroad. This practice continues even though Uganda has acquired the 
requisite high-tech equipment and teams of experts (Ministry of Health, 
2017). There is no kidney donation or transplantation in Uganda because 
laws to govern the procedures have not been developed. However, 
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neighboring Tanzania and Kenya have developed this capacity. Transplants 
occur at two hospitals in Tanzania (Muhimbili National Hospital in Dar es 
Salaam and Benjamin Mkapa Hospital in Dodoma) and seven hospitals in 
Kenya (including Kenyatta National Hospital, Aga Khan Hospital and M.P. 
Shah Hospital in Nairobi, while Moi Teaching and Referral Hospital and St. 
Luke Orthopedic and Trauma Hospital are located in Eldoret, western 
Kenya). In 2019, Kenyan hospitals conducted about 163 kidney transplants. 
Kenya does not have cadaveric organ donation and only uses living donors. 
Most donors (84.5%) are first-degree relatives such as mothers and brothers, 
while a further 14.3% are second-degree relatives such as cousins and 
nephews (Korir, 2020).  
According to Kisanga et al. (2017), in Tanzania, most kidney donors were 
living donors (97.7%).Among the donors for the 44 transplants the authors 
studied, first-degree relatives (59.1%) of donors and second-degree relatives 
were a further 25%.Tanzaniacurrently has the capacity to conduct 200-240 
transplants in a year. 
Uganda refers about 20 patients per year to other countries for kidney 
transplants after thorough preparation of patients. Most referrals are to 
India; a few are to Kenya. The preparation process involves routine dialysis 
and monitoring, screening of the donor for kidney and blood compatibility, 
screening the donor and recipient for other secondary conditions like 
diabetes, hypertension, routine counseling, and referral to the Uganda 
Medical Council for authorization to leave the country for transplantation. 
 
9. Cost of treatment of kidney disease in East Africa 
In Uganda, pre-transplantation tests and activities cost $3,500-$5,750 (12 
million-20 million Ugandan shillings). That figure does not included routine 
dialysis costs. 
The costs of kidney transplant depend on the facility. Patients can be 
referred to hospitals in Tanzania at a total cost of $18,920 (about 66 million 
Ugandan shillings), while in Kenya the cost would be $21,530-27,000 (75 
million-94 million Ugandan shillings).In India, the total cost of 
transplantation is $27,000-32,435 (94 million-113 million Uganda shillings), 
which is roughly 4,000-5,000% of GDP per person. It is estimated that 
transplants in Uganda would cost $5,000- 6,000 (17 million-21 million 
Ugandan shillings), roughly 800-900% of GDP per person. In Uganda, the 
cost of dialysis and transplantation is entirely and directly the responsibility 
of the patient; the country has no National Health Insurance Fund.5 
Kenya and Tanzania each have a National Health Insurance Fund (NHIF) 
that helps cover part of the costs for their citizens. Kenya’s NHIF covers the 
costs of dialysis and the initial transplant surgery. However, the patient has 
to cover the costs of the post-transplant essential medicines 
 
5Costs in this paragraph are rough estimates obtained by interviews of participants. It is not 
clear why the Uganda referral system prefers India, where costs are rather higher than in 
some other countries. 
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(immunosuppressant drugs) that pacify the body’s immune system’s 
reaction to the new organ, reducing the chances of it being rejected (Thuo & 
Riro, 2019).  
Funding for dialysis in Tanzania is through its NHIF, which was initially 
established to cover public servants but now enrolls members from the 
private sector. Tanzania’s NHIF provides full reimbursements for dialysis 
services for its members. Tanzanians not covered by the NHIF must pay out 
of pocket for dialysis services. Thus, only members of this fund have 
guaranteed access to dialysis (Furia et al., 2019). 
Mrs. Kinyi Mbabali has been a widow for over ten years having lost her 
husband to kidney failure in 2009. 
 
”We got to know that my late husband had kidney failure when it was 
too late. The doctors told us about the operations, but we could not raise 
the money to have him taken for a transplant. It was such a hopeless 
situation. We lost our only ‘bread winner’ to kidney failure, and I had 
to be courageous and fend for our children. Some dropped out of 
school; they could not go far with their studies” says the 65 year old 
matriarch, who found at her village home. 
 
 
Mrs. Mbabali seated on a traditional bench at her ancestral home during the 
interview 
 
It was unfortunate for her in her situation and she represents a great 
number of people who painfully lose their loved ones without their voices 
being heard. 
Different patients set up different strategies to raise the funds needed to 
cover the cost, as expressed by Mrs. Kanye Naomi. 
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“My husband decided to list 100 close friends of his who could willfully 
contribute $150 (500,000 Ugandan shillings), he listed institutions to 
which he was a board member, he contacted all the schools where our 
children were at the time both primary and secondary schools, and also 
informed all the staffs he was working with. We also put up an advert 
in a daily newspaper to solicit for well-wishers’ support, and luckily 
we were able to get all the money for the transplant in India.” 
 
She is grateful that she has been given a second chanceat life after a 
successful kidney transplant. 
 
“I thank my husband. I also appreciate my donor. I ask the Government 
of Uganda to sensitize communities about donor safety because there 
are so many communal based myths that had discouraged my donor 
and she almost backed out on me. They should tell people that kidney 
donation is less risky than people think, and both the recipient and the 
donor live normal lives after the process. Also the government should 
step into fully cover or help cover part of the costs of kidney 
transplantation and revamp the effort to institute a functional kidney 
transplant facility in Uganda because the patients suffer too much in 
the foreign countries where they are referred. Lastly, let there be an 
effort to institute a facility where we can get post transplantation 
medicines at a subsidized price because private pharmacies balloon the 
prices of the drugs.” 
 
Although other East African countries have fully implemented a kidney 
donation system and transplantation program, the issue of compensation to 
kidney donors remains silent, limited, and largely restricted and is an out-
of-hospital agreement between the kidney recipient and the donor. Mrs. 
Kanye, the kidney failure survivor, notes this on kidney compensation: 
 
“There should be no sales for the kidneys or any other body organ. The 
government should maintain the current standing statutes or laws. 
However, compensation in kind should be allowed. In my case, we 
offered three in-kind helps to our donor and her family. After the 
transplant, I and my husband helped our donor start a small hotel 
business in the town where she lives and we also helped her husband 
get more markets for his coffee sales. Their son was at that time going 
into secondary school, we have since sponsored that child’s education. 
He is at the University now. We treat the boy as our own child.” 
 
There remains a great desire to institute transparent kidney registries and 
allow a legally acceptable and public kidney donation and compensation 
program in most of the countries. Uganda has fallen behind other East 
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10. East African law concerning transplants 
Tanzania, despite having a kidney transplantation program at two 
hospitals, still lacks a strong legal framework for organ donation. There is no 
legislation on the subject. Kidney transplantation services are offered in 
observation of the Istanbul declaration on organ trafficking and transplant 
tourism and the special guidelines in the Muhimbili National Hospital 
Establishment Act (Furia et al. 2019). The lack of a stronger framework may 
limit the ability to carry out more transplants in Tanzania. 
Uganda’s Mulago National Referral Hospital by October 2018 had 
acquired high-tech equipment and teams of expert nephrologists, 
physicians, surgeons and nurses to carry out the numerous tests before 
conducting kidney transplants. The greatest hindrance to the big leap 
forward has been the absence of an enabling law to facilitate kidney 
transplantation in the country. The enabling law still remains a policy (bill) 
paper, though, as of October 2020, the bill has been approved by the Cabinet 
and now awaits review and approval by the Parliament. The principles of 
this bill include: 
 Establishing a legal framework for human organ, cell, and tissue 
transplants in Uganda by enacting the Uganda Human Organ 
Transplant Bill. 
 Regulating donations and trade in human organs, cells, and tissues. 
 Reducing government expenditure on referrals abroad for organ 
transplant procedures. 
For the bill to become law, it needs approval by Parliament and then 
obtain Presidential assent. Once the bill is an act of law, it will enable and 
regulate the performance of organ transplants, donations, harvesting, 
exportation, and importation. 
Kenya already has a functional and fully enacted law that governs organ 
transplantation. The lawis part of the larger Health Bill 2016 and builds on 
the Human Tissue Act, which was reviewed in 2012. It allows Kenyans, 
either in a written will or an oral statement before witnesses, to donate their 
bodies or body parts to persons or institutions of their choice upon death. In 
the absence of a will, however, the law states that “the spouse or spouses, 
elder child, parent, guardian, eldest brother or sister of that person, in the 
specific order mentioned, may, after that person’s death, donate the body or 
any specific tissue of that body to an institution or a person contemplated in 
this subsection.” According to the law, the Cabinet Secretary for Health can 
also step in and donate an individual’s organs in the event that the relatives 
of the deceased person cannot be traced and no will is left behind. Donations 
may be made for training medical students in learning institutions, for 
research or advancement of health services, or for healing purposes, 
including the use of tissue in any living person. 
The Kenyan law further provides that any transplant of tissues must be 
done in a duly authorized health facility after approval from a medical 
practitioner in charge of clinical services in that facility. The law ensures that 
doctors and other health professionals do not coerce patients into untimely 
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removal of organs. It stipulates that a doctor who authorizes such a 
procedure shall not play a leading role in the transplantation to the other 
party. The law also comes with a hefty fine of up to $92,500 (10 million 
Kenyan shillings), about 5,400% of GDP per person in Kenya, or ten years in 
jail or both for anyone found selling life-saving organs for cash. The law in 
Kenya opens a way for a legal and regulated mechanism for donations from 
non-relatives (Thuo & Riro, 2019; Merab, 2017). 
Kenya and Tanzania have made strides in instituting organ donations and 
transplantation laws. Other East African countries, including Uganda, 
Rwanda, Burundi, and South Sudan 6 lag behind in enacting laws and 
instituting transplantation services. Compensation to kidney (or organ) 
donors remains an omission of focus and largely a silent issue in all 
countries. 
 
Table 1. Summary of kidney disease data in East Africa 
No. Key  Kenya Tanzania Uganda 
01 People with kidney disease 4 million  Not available Not available 
02 Annual deaths from KD About 10,000  4,704 patients7 Not available 
03 Number of dialysis centres Not available 17 centres 2 public hospitals 
04 Number of dialysis machines Not available 104 machines 45 machines 
05 Number of dialysis patients  Not available 600 patients Not available 
06 Estimated cost of dialysis8  9,500= 250,000= 350,000= 
07 Transplant hospitals 7 hospitals 2 hospitals None 
08 Annual transplants, latest 163 transplants 56transplants9 None 
09 Living/ deceased donors All living All living None 
10 Cost of local transplant10 0.25-3 million= 21 million= Not applicable 
11 Cost out of country Not applicable Not applicable 100-150 million 
12 Who pays for the transplant NHIF,patient NHIF Patient 
13 Government law on donation Available Not available11 Not available 
14 Professional expertise  Available Available Available12 
 
11. Current efforts to improve treatment for kidney 
diseases in East Africa 
In Uganda, the general perception is that, where it exists, the effort to 
improve treatment for kidney disease is not institutional, but individual. It 
arises mainly from key leading urologists who set up private dialysis centers 
 
6 Rwanda, Burundi and South Sudan are East African Community member states but are 
omitted from the discussion in the rest of the paper. 
7 As of 2014; no recent data available. 
8 Cost of dialysis per session, in units of local currency (Kenyan, Tanzanian, or Ugandan 
shillings). 
9  As of 2017; no recent data available. In some parts of this paper, I indicate 200-240 
transplants. The reader must understand that this estimate demonstrates that Tanzania has 
developed capacity to conduct 200-240 transplants in a single year; this is not the number of 
transplants in the latest year.  
10Expressed in units of local currency. Cost of transplant depends on facility ownership; 
government or private, and whether patient has NHIF coverage or not. 
11  Though Tanzania has no law, transplantation is conducted following the Istanbul 
declaration and the Muhimbili National Hospital establishment act. 
12 In Uganda, though professional resources are available, more training might be required. 
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and personally give counsel to their patients. The government has made 
minimal effort, setting up only one public centre for dialysis in the capital. 
At this public centre, the patients are charged a service fee per session and 
have to provide the dialysis circuit supplies themselves. In the future, the 
national referral hospital may start kidney transplants, but the fear remains 
that patients needing the service may have to first solicit large sums of 
money to pay for it. 
In Kenya and Tanzania it is evident that gains have occurred regarding 
kidney transplantation. Tanzania has worked with the Tokushukai Medical 
Group, Tokyo Women’s Medical University, and Nipro Laboratory Co. 
(Osaka, Japan) to institute kidney transplantation at Benjamin Mkapa 
Hospital in Dodoma. The effort included donating 161 dialysis machines 
with reverse osmosis and demineralization water clean systems to 15 Sub-
Saharan countries, initiating kidney transplantation in Tanzania, educating 
medical staffs, and providing modern specialties in diagnostic and curative 
services (Shuzo & Shumi, 2020). After overcoming difficulties including poor 
electricity and water supply systems, bureaucratic delays over procurement 
procedures, constructing a state-of-the-art kidney transplant theater, 
training, and getting medical staffs accustomed to medical equipment, the 
Tanzanian team conducted a kidney transplant on 22 March 2018. It was the 
first kidney transplant by a Tanzanian staff, for a Tanzanian patient. This 
success was followed by another seven kidney transplants later that year at 
Benjamin Mkapa Hospital. This complimented kidney transplant gains 
made at Muhimbili National Hospital in Dar es Salaam. 
It is desirable to initiate similar efforts elsewhere in East Africa so that 
patients with kidney failure are not ignored, and to satisfy the goal expressed 
by the 2015 World Congress of Nephrology in Cape Town that “No one 
should die of untreated acute kidney injury by 2025” (Etienne et al. 2019). 
 
12. Ideas for steps for the near future 
Great gaps of information exist concerning kidney donation, 
transplantation, and compensation to kidney donors in East Africa. I hope 
that this paper will encourage other researchers to gather and publish data. 
Some of the outstanding questions include: 
 How many people officially die of kidney disease in East African 
countries per year? 
 How many patients are on renal dialysis in individual East African 
countries? 
 What is the agreeable and affordable cost of dialysis and kidney 
transplants, and how many people can comfortably and privately 
afford this cost? If people cannot afford the cost of transplants, how 
do governments of countries without health insurance policies step 
in to support patients? 
 How can costs to patients be reduced so as to improve accessibility 
to dialysis and transplantation services and thus improve the quality 
of life? 
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 Are living donors in East Africa at a high risk of developing 
complications after transplantation compared to non donors? 
 Why is the issue of compensating kidney (or organ) donors a serious 
omission of focus, yet one that could solve the grinding scarcity of 
kidney (or organ) shortage? 
 Are there peculiar medical characteristics of the East African 
population that would affect the question of compensation for organ 
donors, and how can compensation be legalized to achieve 
availability of organs to save lives? 
In developing a kidney transplant system in Uganda and other East Africa 
Community states, major areas still require public sensitization and 
education. They include ethical, religious, and cultural perspectives on organ 
donation and compensation. Laws should apply to organ transplants from 
living and deceased donors alike. Proper sensitization is also required in 
dealing with the contentious issues of who are “the rightful heirs,” 
appropriate authorities to make decisions in the absence of a will, and the 
government’s role in the case of unclaimed bodies. Governments also need 
to develop positions on how much of the cost of transplants they are willing 
to pay, negotiations for compensating kidney donors, and how they will 
punish organ traffickers or other law breakers. Physicians, medical 
laboratory scientists, biomedical engineers, nurses, and counselors all need 
appropriate training. 
To evaluate the anticipated contribution of kidney transplants in Uganda, 
there needs to be a database for donors and recipients, greater capacity to 
offer dialysis and perform kidney transplants, and clarity about offering 
donor compensation. Taking those steps would reduce deaths from kidney 
disease and improve the quality of life for survivors. The healthcare system 
should monitor immunosuppressive protocols and follow up with donors 
and recipients to provide emotional, medical, and psychological support. It 
should not only be the patients’ responsibility. All these are gaps that require 
thorough examination so as to reap the best outcomes. A survey to estimate 
the extent of kidney disease and assess public knowledge and attitudes 
towards it would provide the basis for more precise estimates of the costs of 
kidney diseases and the benefits of compensating organ donors, and would 
provide answers to other important questions. 
 
Abbreviations and synonyms 
AKI: Acute Kidney Injury 
BMH: Benjamin Mkapa Hospital 
CKD: Chronic Kidney Disease 
ESRD: End-Stage Renal Disease 
GDP: Growth Domestic Product 
GFR: Glomerular Filtration Rate 
HIV: Human Immunodeficiency Virus 
NCD: Non-Communicable Disease 
NHIF: National Health Insurance Fund 
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NR: Normal Range 
RRT: Renal Replacement Therapy 
 
13. Operational definitions 
Acute kidney injury (AKI): Abrupt decrease in kidney function, resulting 
in the retention of urea and other waste, and in dysregulation of extracellular 
volume and electrolytes. 
Chronic kidney disease (CKD): A kidney disease that has lasted a long 
time. 
Comorbidity: The coexistence of multiple disorders in the same patient. 
Glomerular Filtration Rate (GFR): A calculation that determines how well 
the blood is filtered by the kidneys, which is one of the ways to measure 
remaining kidney function. 
Hemodialysis: The process of purifying the blood of a person whose 
kidneys are not working properly. 
Kidney failure: Used to mean End-Stage Renal Disease (ESRD)in this 
article. 
Metabolic acid load: Metabolic balance of acid-inducing foods and base-
inducing foods. 
Metabolism: Chemical processes that occur within a living organism in 
order to maintain life. 
Morbidity: Having a disease or a symptom of a disease, or the amount of 
disease within a population. 
Mortality: The state of being susceptible to death. 
Neuropathy: A disease or dysfunction of one or more nerves, typically 
causing weakness, numbness, and pain. 
Non communicable Disease: A noninfectious health condition (no person 
to person spread).  
Normal Range (NR): A range of values deemed normal for physiologic 
measurement in health.  
Risk factor: Something that increases a person’s chances of developing a 
disease. 
Serum electrolytes: Minerals present in the blood and body tissues, and 
essential for metabolism. 
Transplant tourism: Overseas transplantation in which a patient obtains 
an organ through organ trade or other forms the organ trade may take. 
Travel for transplantation: The movement of organs, donors, recipients, 
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